NanoSyrinx

NanoSyrinx is a discovery-stage synthetic biology company developing a platform technology for the targeted intracellular delivery of biological molecules. The company engineers bacterial nanomachines, referred to as Nanosyringes, to deliver protein therapeutics directly into the interior of cells. This technology aims to address the bioavailability challenges of biologic drugs like antibodies and peptides, targeting the estimated 80% of intracellular targets that are currently undruggable.